Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-14.9%
5Y CAGR-7.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-14.9%/yr
vs -1.9%/yr prior
5Y CAGR
-7.6%/yr
Recent deceleration
Acceleration
-13.0pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.59 | -35.4% |
| 2024 | 2.46 | -47.4% |
| 2023 | 4.67 | +81.4% |
| 2022 | 2.57 | +3.0% |
| 2021 | 2.50 | +6.2% |
| 2020 | 2.35 | -1.1% |
| 2019 | 2.38 | -14.4% |
| 2018 | 2.78 | +5.6% |
| 2017 | 2.63 | +3.6% |
| 2016 | 2.54 | - |